Companies Restart Vaccine Trials After Volunteers Experience UNRELATED Illness

( Johnson & Johnson and AstraZeneca have restarted their late-stage COVID-19 vaccine trials after volunteers fell sick. Despite media reports implying that the trials were halted over fears that the volunteers had become ill from the vaccine, the companies involved in the trials were aware that volunteers who fell ill were part of the control group and had not been administered the vaccine.

According to the New York Times, federal health regulators gave the pharmaceutical companies the green light to continue the trials after a six-week pause that has significantly delayed progress in getting the vaccine out to the public. The authorities concluded that there was no evidence that the experimental vaccine had caused the neurological problems that were reported in two of the participants.

Johnson & Johnson reportedly said that its own trial, which had been on pause for a total of 11 days, would begin after learning that one of their study volunteers who had a “serious medical event” didn’t have a clear cause.

While it means there has been a delay in the confirmation that the vaccines work, experts still believe that the vaccine trials are moving along quickly and that they could soon be administered to the public to stop the spread of the disease.

Last week, the New York Times reported how experts now have “genuine confidence” that the COVID-19 pandemic will end “far sooner” than originally expected. The left-wing outlet was forced to admit that Operation Warp Speed, a plan put in place by President Donald Trump to reduce the time it takes to complete various bureaucratic processes, was working. The president’s efforts to speed up development, manufacturing and distribution of therapeutics and vaccines was “working with remarkable efficiency.”

So President Trump does have a clear plan, right, Joe Biden?

The Times even said that the United States is “faring much better than it did during the Spanish influenza,” which saw some 700,000 people dead from the virus.

Must be tough for the New York Times to admit that, given the media and Democratic Party’s campaign to portray the president as having failed on managing the outbreak.

Now the vaccine trials have restarted, experts believe that mobilization could be well underway by early 2021. President Donald Trump has also suggested he may be able to deliver the vaccine nationally before the end of the year.